MDEVvsFTXHETF Comparison
VS
First Trust Indxx Medical Devices ETF (MDEV) belongs to the Healthcare Technology segment. First Trust Nasdaq Pharmaceuticals ETF (FTXH) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Healthcare. MDEV is more expensive with a Total Expense Ratio (TER) of 0.7%, versus 0.6% for FTXH. MDEV is down -3.05% year-to-date (YTD) with +$994K in YTD flows. FTXH performs better with 19.76% YTD performance, and +$886M in YTD flows. Run a side-by-side ETF comparison of MDEV and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
MDEV vs FTXH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/30/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | MDEV FTXH | +6.20%+2.94% | +9.77%+16.36% | -3.05%+19.76% | -0.45%+50.66% | -2.20%+54.62% | -23.17%+59.45% |
| Flows | MDEV FTXH | +$994K+$876M | +$994K+$876M | +$994K+$886M | +$994K+$889M | +$767K+$878M | -$23M+$881M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | MDEV FTXH | +17.24%+17.96% | +16.50%+17.07% | +16.33%+16.60% | +19.16%+16.10% |
| Max drawdown | MDEV FTXH | -3.88%-4.43% | -18.07%-7.50% | -21.75%-19.32% | -42.16%-19.32% |
| Max drawdown duration | MDEV FTXH | 11d20d | 205d99d | 205d393d | 1787d393d |
Trading data
MDEV | FTXH | |
Last sale 7/31/2026 at 1:30 PM | $20.24 | $38.89 |
| Previous close 07/30/2026 | $20.16 | $39.30 |
| Consolidated volume 07/30/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
MDEV | FTXH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/31/2026 at 1:30 PM
Live
Closed
MDEV | FTXH | |
|---|---|---|
| Last price | $20.24 | $38.89 |
| 1D performance | +0.39% | -1.05% |
| AuM | $3.06 M | $920.98 M |
| E/R | 0.7% | 0.6% |
Characteristics
MDEV | FTXH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | First Trust | First Trust |
| Benchmark | Indxx Global Medical Equipment Index | NASDAQ US Smart Pharmaceuticals Index |
| N° of holdings | 47 | 50 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 23, 2021 | September 20, 2016 |
| ESG | No | No |
Advertisement
Exposure
Countries
MDEV
USA
55.63%
Japan
7.86%
Other
36.51%
FTXH
USA
95.49%
Other
4.51%
Sectors
MDEV
Healthcare
95.26%
Other
4.74%
FTXH
Healthcare
99.86%
Other
0.14%
Advertisement
Diversification
MDEV
Total weight of top 15 holdings out of 15
35.95%
FTXH
Total weight of top 15 holdings out of 15
66.57%
Top 15 holdings
Data as of June 30, 2026
MDEV
West Pharmaceutical Services, Inc.
2.88%
Demant A/S
2.76%
LivaNova Plc
2.67%
Baxter International, Inc.
2.57%
Revvity, Inc.
2.55%
WuXi AppTec Co., Ltd.
2.41%
Waters Corp.
2.40%
Edwards Lifesciences Corp.
2.40%
Agilent Technologies, Inc.
2.36%
Teleflex, Inc.
2.23%
DexCom, Inc.
2.18%
Bio-Rad Laboratories, Inc.
2.16%
Sonova Holding AG
2.13%
Align Technology, Inc.
2.13%
Sysmex Corp.
2.12%
FTXH
Eli Lilly & Co.
7.74%
AbbVie, Inc.
7.39%
Johnson & Johnson
6.98%
Merck & Co., Inc.
6.92%
Bristol Myers Squibb Co.
6.18%
Biogen, Inc.
3.73%
Viatris, Inc.
3.70%
Cardinal Health, Inc.
3.54%
Vertex Pharmaceuticals, Inc.
3.42%
Amgen, Inc.
3.18%
Pfizer Inc.
2.95%
Gilead Sciences, Inc.
2.89%
United Therapeutics Corp.
2.76%
Regeneron Pharmaceuticals, Inc.
2.73%
Jazz Pharmaceuticals Plc
2.46%
Frequently asked questions about MDEV and FTXH
How have the MDEV and FTXH ETFs performed in 2026?
As of July 30, 2026, MDEV is down -3.05% year-to-date (YTD), while FTXH has returned 19.76%. That puts FTXH better performer ahead so far this year.
Which ETF is attracting more investor money: MDEV or FTXH?
Year-to-date, the MDEV ETF saw +$994K in flows, compared to +$886M for FTXH.
Which ETF is more volatile: MDEV or FTXH?
Over the past year, MDEV had a volatility of 16.5%, while FTXH experienced 17.07%.
Which ETF is bigger: MDEV or FTXH?
As of July 30, 2026, MDEV holds $3.06 M in assets under management (AUM), while FTXH manages $920.98 M.
What sectors do the MDEV and FTXH ETFs invest in?
MDEV leans toward sectors like Healthcare. Meanwhile, FTXH focuses on Healthcare.
What are the top holdings of the MDEV ETF and FTXH ETF?
MDEV top holdings include West Pharmaceutical Services, Inc., Demant A/S and LivaNova Plc. FTXH holds in its top three: Eli Lilly & Co., AbbVie, Inc. and Johnson & Johnson.
Which ETF is more diversified: MDEV or FTXH?
MDEV holds 47 securities with 35.95% of its assets in the top 15. FTXH has 50 securities and a top 15 weight of 66.57%.
Advertisement
Advertisement
